Literature DB >> 24135265

A probabilistic approach to explore human miRNA targetome by integrating miRNA-overexpression data and sequence information.

Yue Li1, Anna Goldenberg, Ka-Chun Wong, Zhaolei Zhang.   

Abstract

MOTIVATION: Systematic identification of microRNA (miRNA) targets remains a challenge. The miRNA overexpression coupled with genome-wide expression profiling is a promising new approach and calls for a new method that integrates expression and sequence information.
RESULTS: We developed a probabilistic scoring method called targetScore. TargetScore infers miRNA targets as the transformed fold-changes weighted by the Bayesian posteriors given observed target features. To this end, we compiled 84 datasets from Gene Expression Omnibus corresponding to 77 human tissue or cells and 113 distinct transfected miRNAs. Comparing with other methods, targetScore achieves significantly higher accuracy in identifying known targets in most tests. Moreover, the confidence targets from targetScore exhibit comparable protein downregulation and are more significantly enriched for Gene Ontology terms. Using targetScore, we explored oncomir-oncogenes network and predicted several potential cancer-related miRNA-messenger RNA interactions.
AVAILABILITY AND IMPLEMENTATION: TargetScore is available at Bioconductor: http://www.bioconductor.org/packages/devel/bioc/html/TargetScore.html.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24135265     DOI: 10.1093/bioinformatics/btt599

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  14 in total

1.  Integrating full spectrum of sequence features into predicting functional microRNA-mRNA interactions.

Authors:  Zixing Wang; Wenlong Xu; Yin Liu
Journal:  Bioinformatics       Date:  2015-06-30       Impact factor: 6.937

2.  Inferring probabilistic miRNA-mRNA interaction signatures in cancers: a role-switch approach.

Authors:  Yue Li; Cheng Liang; Ka-Chun Wong; Ke Jin; Zhaolei Zhang
Journal:  Nucleic Acids Res       Date:  2014-03-07       Impact factor: 16.971

3.  Genome-wide cross-cancer analysis illustrates the critical role of bimodal miRNA in patient survival and drug responses to PI3K inhibitors.

Authors:  Laura Moody; Guanying Bianca Xu; Yuan-Xiang Pan; Hong Chen
Journal:  PLoS Comput Biol       Date:  2022-05-31       Impact factor: 4.779

4.  mirDIP 4.1-integrative database of human microRNA target predictions.

Authors:  Tomas Tokar; Chiara Pastrello; Andrea E M Rossos; Mark Abovsky; Anne-Christin Hauschild; Mike Tsay; Richard Lu; Igor Jurisica
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

5.  DNA microarray integromics analysis platform.

Authors:  Tomasz Waller; Tomasz Gubała; Krzysztof Sarapata; Monika Piwowar; Wiktor Jurkowski
Journal:  BioData Min       Date:  2015-06-25       Impact factor: 2.522

6.  Potential microRNA-mediated oncogenic intercellular communication revealed by pan-cancer analysis.

Authors:  Yue Li; Zhaolei Zhang
Journal:  Sci Rep       Date:  2014-11-18       Impact factor: 4.379

7.  miRLAB: An R Based Dry Lab for Exploring miRNA-mRNA Regulatory Relationships.

Authors:  Thuc Duy Le; Junpeng Zhang; Lin Liu; Huawen Liu; Jiuyong Li
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

8.  A novel semi-supervised model for miRNA-disease association prediction based on [Formula: see text]-norm graph.

Authors:  Cheng Liang; Shengpeng Yu; Ka-Chun Wong; Jiawei Luo
Journal:  J Transl Med       Date:  2018-12-14       Impact factor: 5.531

9.  Transcriptional override: a regulatory network model of indirect responses to modulations in microRNA expression.

Authors:  Christopher G Hill; Lilya V Matyunina; Deette Walker; Benedict B Benigno; John F McDonald
Journal:  BMC Syst Biol       Date:  2014-03-25

10.  Improving microRNA target prediction with gene expression profiles.

Authors:  Cesaré Ovando-Vázquez; Daniel Lepe-Soltero; Cei Abreu-Goodger
Journal:  BMC Genomics       Date:  2016-05-17       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.